Anthracene

Anthracene

SCHEMBL7079431

c1ccc2cc3ccccc3cc2c1.c1ccc2sccc2c1

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.42
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
CA12 O43570 5/20 0.39
CA2 P00918 3/20 0.39
DYRK1A Q13627 1/20 0.38
CA9 Q16790 2/20 0.38
PTPRC P08575 1/20 0.38
PTPN6 P29350 1/20 0.38
PTPN11 Q06124 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
RPS6KB2 Q9UBS0 1/20 0.36
GPR3 P46089 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HBB P68871 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzothiophene SCHEMBL17443004 0.98 CYP2A6 (0.41) CYP2A6CTNNB1WNT3ACA12CA2
Benz(B)Anthracene SCHEMBL29132953 0.98 CYP2A6 (0.41) CYP2A6CTNNB1WNT3ACA12CA2
Benzothiophene SCHEMBL29415494 0.92
Benzothiophene SCHEMBL451494 0.92
Benzothiophene SCHEMBL28399890 0.92 CA12 (0.42) CYP2A6CTNNB1WNT3ACA12CA2
Benzothiophene SCHEMBL28545602 0.92 CA12 (0.42) CYP2A6CTNNB1WNT3ACA12CA2
Benzothiophene SCHEMBL29383883 0.92
Benzothiophene SCHEMBL7023 0.92
Benzothiophene SCHEMBL253491 0.92 CA12 (0.42) CYP2A6CTNNB1WNT3ACA12CA2
Benzothiophene SCHEMBL27873783 0.92 CA12 (0.42) CYP2A6CTNNB1WNT3ACA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003526594-A 2003-09-09 JP claimed
EP-0996434-A4 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORP (US) 2001-10-10 EP claimed
EP-0996434-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH Adolor Corporation (US) 2000-05-03 EP claimed
WO-1999003459-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORPORATION (US) 1999-01-28 WO claimed
CN-101391992-A Substituted anthracene benzothiophene compounds and preparation method and use thereof CHINESE ACAD INST CHEMISTRY (CN) 2009-03-25 CN disclosed
CN-101391992-A Substituted anthracene benzothiophene compounds and preparation method and use thereof CHINESE ACAD INST CHEMISTRY (CN) 2009-03-25 CN disclosed
CN-101391992-A Substituted anthracene benzothiophene compounds and preparation method and use thereof CHINESE ACAD INST CHEMISTRY (CN) 2009-03-25 CN disclosed